Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT06043817. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04685070. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
ClinicalTrials.gov study NCT06827145. IPD Sharing: NO. Countries: 1. Publications: 0.
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
ClinicalTrials.gov study NCT05810350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Sma
ClinicalTrials.gov study NCT06970639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplifi
ClinicalTrials.gov study NCT02468661. IPD Sharing: NO. Countries: 10. Publications: 0.
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
ClinicalTrials.gov study NCT07100080. IPD Sharing: YES. Countries: 25. Publications: 0.
Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive
ClinicalTrials.gov study NCT07063329. IPD Sharing: NO. Countries: 1. Publications: 0.
Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT06752408. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT07183189. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resectio
ClinicalTrials.gov study NCT07128199. IPD Sharing: NO. Countries: 24. Publications: 0.
Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB
ClinicalTrials.gov study NCT02326285. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation
ClinicalTrials.gov study NCT06015568. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT05256290. IPD Sharing: NO. Countries: 1. Publications: 0.
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
ClinicalTrials.gov study NCT07089641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05442060. IPD Sharing: NO. Countries: 1. Publications: 0.
T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC
ClinicalTrials.gov study NCT03784599. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
ClinicalTrials.gov study NCT07117890. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR Mutation Targeting Molecular Probe for PET Imaging
ClinicalTrials.gov study NCT06641674. IPD Sharing: NO. Countries: 1. Publications: 0.
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation
ClinicalTrials.gov study NCT03399669. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.